Yam T S, Hamilton-Miller J M, Shah S
Department of Medical Microbiology, Royal Free Hospital School of Medicine, London, UK.
J Antimicrob Chemother. 1998 Aug;42(2):211-6. doi: 10.1093/jac/42.2.211.
Extracts of tea (Camellia sinensis) can reverse methicillin resistance in methicillin-resistant Staphylococcus aureus (MRSA) and also, to some extent, penicillin resistance in beta-lactamase-producing S. aureus. These phenomena are explained by prevention of PBP2' synthesis and inhibition of secretion of beta-lactamase, respectively. Synergy between beta-lactams and tea extracts were demonstrated by disc diffusion, chequerboard titration and growth curves. Partition chromatography of an extract of green tea on Sephadex LH-20 yielded several fractions, one of which contained a virtually pure compound that showed the above-mentioned activities, at concentrations above about 2 mg/L. The observed activities are novel and distinct from the previously reported direct antibacterial activity of tea extracts. Prevention of PBP2' synthesis offers an interesting possible new approach for the treatment of infections caused by MRSA.
茶叶(茶树)提取物可逆转耐甲氧西林金黄色葡萄球菌(MRSA)的甲氧西林耐药性,并且在一定程度上还能逆转产β-内酰胺酶金黄色葡萄球菌的青霉素耐药性。这些现象分别通过预防PBP2'的合成和抑制β-内酰胺酶的分泌来解释。通过纸片扩散法、棋盘滴定法和生长曲线证明了β-内酰胺类药物与茶叶提取物之间的协同作用。绿茶提取物在Sephadex LH-20上进行分配色谱分离得到几个馏分,其中一个馏分含有一种几乎纯的化合物,该化合物在浓度高于约2 mg/L时表现出上述活性。观察到的这些活性是新颖的,且与先前报道的茶叶提取物的直接抗菌活性不同。预防PBP2'的合成提供了一种有趣的、可能用于治疗由MRSA引起的感染的新方法。